D.E. Shaw & Co’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BIO
D.E. Shaw & Co's BIO Position: Q3 2026 in Review
D.E. Shaw & Co increased its Bio-Rad Laboratories Class A (BIO) stake by 402% in Q3 2026, buying an estimated $27M and bringing the position to 96,719 shares worth $36.5M. The position accounts for 0.02% of the portfolio, ranked #946.
D.E. Shaw & Co first reported a position in BIO in Q2 2013 and has held it in 54 quarters since. The position peaked at $59.6M in Q3 2018. 419 funds tracked by Wall St. Rank hold BIO as of Q3 2026.
- D.E. Shaw & Co held 96,719 shares of Bio-Rad Laboratories Class A worth $36.5M as of Q3 2026.
- D.E. Shaw & Co bought 77,463 Bio-Rad Laboratories Class A shares in Q3 2026, an estimated $27M.
- Bio-Rad Laboratories Class A made up 0.02% of D.E. Shaw & Co's portfolio in Q3 2026, its #946 holding.
- D.E. Shaw & Co first reported a position in Bio-Rad Laboratories Class A in Q2 2013 and has held it in 54 quarters since.
- D.E. Shaw & Co's Bio-Rad Laboratories Class A position peaked at $59.6M in Q3 2018.
- 419 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.
Based on D.E. Shaw & Co's 13F filing for Q3 2026, filed 16 Nov 2026.